Stoke Therapeutics Stock Price History
| STOK Stock | USD 12.91 0.06 0.47% |
Below is the normalized historical share price chart for Stoke Therapeutics extending back to June 19, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Stoke Therapeutics stands at 12.91, as last reported on the 4th of August, with the highest price reaching 13.01 and the lowest price hitting 12.41 during the day.
If you're considering investing in Stoke Stock, it is important to understand the factors that can impact its price. Stoke Therapeutics appears to be not too volatile, given 3 months investment horizon. Stoke Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.2, which indicates the firm had a 0.2 % return per unit of risk over the last 3 months. By inspecting Stoke Therapeutics' technical indicators, you can evaluate if the expected return of 0.67% is justified by implied risk. Please review Stoke Therapeutics' Semi Deviation of 3.0, risk adjusted performance of 0.1254, and Coefficient Of Variation of 669.58 to confirm if our risk estimates are consistent with your expectations. The value of Total Stockholder Equity is estimated to slide to about 193.3 M. The value of Common Stock Total Equity is estimated to slide to 2,750. At this time, Stoke Therapeutics' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 2.73 this year, although the value of Price To Operating Cash Flows Ratio will most likely fall to (7.20). Stoke Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of June 2019 | 200 Day MA 10.568 | 50 Day MA 11.597 | Beta 1.142 |
Sharpe Ratio = 0.2029
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | STOK | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.32 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.67 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Stoke Therapeutics is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stoke Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.015 | Enterprise Value Ebitda 8.6886 | Price Sales 3.6921 | Shares Float 37.8 M | Wall Street Target Price 23.2222 |
Stoke Therapeutics Stock Price History Chart
There are several ways to analyze Stoke Stock price data. The simplest method is using a basic Stoke candlestick price chart, which shows Stoke Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 23, 2025 | 14.27 |
| Lowest Price | May 13, 2025 | 8.93 |
Stoke Therapeutics August 4, 2025 Stock Price Synopsis
Various analyses of Stoke Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Stoke Stock. It can be used to describe the percentage change in the price of Stoke Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Stoke Stock.| Stoke Therapeutics Price Daily Balance Of Power | 0.10 | |
| Stoke Therapeutics Price Rate Of Daily Change | 1.00 | |
| Stoke Therapeutics Price Action Indicator | 0.23 |
Stoke Therapeutics August 4, 2025 Stock Price Analysis
Stoke Stock Price History Data
The price series of Stoke Therapeutics for the period between Tue, May 6, 2025 and Mon, Aug 4, 2025 has a statistical range of 5.61 with a coefficient of variation of 12.51. The price distribution for the period has arithmetic mean of 11.08. The median price for the last 90 days is 11.51. The company completed stock split (1:9) on 6th of June 2019.| Open | High | Low | Close | Volume | ||
08/04/2025 | 12.85 | 13.01 | 12.41 | 12.91 | ||
08/04/2025 | 12.85 | 13.01 | 12.41 | 12.91 | ||
08/01/2025 | 12.52 | 13.01 | 12.41 | 12.91 | 426,812 | |
07/31/2025 | 12.78 | 12.95 | 12.55 | 12.85 | 550,827 | |
07/30/2025 | 12.68 | 13.12 | 12.61 | 12.87 | 560,136 | |
| 07/29/2025 | 12.88 | 12.88 | 12.25 | 12.50 | 823,029 | |
07/28/2025 | 13.11 | 13.22 | 12.73 | 12.81 | 622,885 | |
07/25/2025 | 13.45 | 13.45 | 12.55 | 13.10 | 728,827 | |
07/24/2025 | 14.52 | 14.71 | 13.15 | 13.51 | 1,017,626 | |
07/23/2025 | 14.80 | 14.99 | 13.81 | 14.27 | 1,449,707 | |
| 07/22/2025 | 13.50 | 14.78 | 13.31 | 13.57 | 2,523,356 | |
07/21/2025 | 13.25 | 13.31 | 12.26 | 12.31 | 617,050 | |
| 07/18/2025 | 12.93 | 14.50 | 12.54 | 13.22 | 1,552,692 | |
| 07/17/2025 | 11.93 | 12.39 | 11.89 | 12.35 | 465,987 | |
07/16/2025 | 11.83 | 12.05 | 11.69 | 11.90 | 678,034 | |
| 07/15/2025 | 12.11 | 12.11 | 11.66 | 11.75 | 535,075 | |
07/14/2025 | 11.83 | 12.08 | 11.81 | 12.06 | 488,154 | |
07/11/2025 | 11.92 | 12.03 | 11.76 | 11.86 | 545,119 | |
| 07/10/2025 | 12.02 | 12.42 | 11.71 | 12.04 | 596,598 | |
| 07/09/2025 | 12.18 | 12.46 | 11.90 | 12.02 | 605,399 | |
07/08/2025 | 11.73 | 12.25 | 11.70 | 12.01 | 594,565 | |
07/07/2025 | 11.45 | 11.80 | 11.43 | 11.69 | 534,606 | |
07/03/2025 | 11.58 | 11.65 | 11.36 | 11.48 | 185,804 | |
07/02/2025 | 11.45 | 11.86 | 11.32 | 11.55 | 403,439 | |
| 07/01/2025 | 11.25 | 12.00 | 11.19 | 11.65 | 466,575 | |
| 06/30/2025 | 11.69 | 11.69 | 11.31 | 11.35 | 509,367 | |
06/27/2025 | 11.97 | 12.13 | 11.56 | 11.63 | 1,371,546 | |
06/26/2025 | 11.78 | 11.90 | 11.35 | 11.84 | 552,870 | |
06/25/2025 | 11.45 | 11.90 | 11.17 | 11.81 | 629,232 | |
06/24/2025 | 11.75 | 12.14 | 11.49 | 11.51 | 603,235 | |
06/23/2025 | 11.56 | 11.76 | 11.35 | 11.59 | 421,726 | |
06/20/2025 | 11.68 | 11.96 | 11.35 | 11.58 | 867,355 | |
06/18/2025 | 11.64 | 12.25 | 11.51 | 11.57 | 444,834 | |
06/17/2025 | 11.70 | 11.95 | 11.50 | 11.66 | 595,406 | |
06/16/2025 | 11.69 | 11.74 | 11.43 | 11.70 | 438,445 | |
| 06/13/2025 | 11.48 | 11.79 | 11.43 | 11.53 | 478,279 | |
06/12/2025 | 11.50 | 11.86 | 11.38 | 11.82 | 500,444 | |
06/11/2025 | 11.48 | 11.81 | 11.36 | 11.50 | 401,125 | |
06/10/2025 | 11.13 | 11.48 | 11.12 | 11.36 | 445,082 | |
06/09/2025 | 11.31 | 11.31 | 10.90 | 11.13 | 452,081 | |
06/06/2025 | 11.05 | 11.35 | 11.05 | 11.14 | 463,070 | |
06/05/2025 | 10.89 | 11.00 | 10.64 | 10.88 | 372,305 | |
06/04/2025 | 10.89 | 11.42 | 10.83 | 10.94 | 598,822 | |
| 06/03/2025 | 9.94 | 11.11 | 9.84 | 10.90 | 1,384,080 | |
| 06/02/2025 | 9.65 | 10.00 | 9.47 | 9.91 | 518,058 | |
05/30/2025 | 9.62 | 9.70 | 9.36 | 9.54 | 375,650 | |
05/29/2025 | 9.57 | 9.83 | 9.34 | 9.73 | 453,308 | |
05/28/2025 | 9.24 | 9.65 | 9.09 | 9.43 | 464,852 | |
05/27/2025 | 9.55 | 9.71 | 9.13 | 9.18 | 525,853 | |
05/23/2025 | 9.30 | 9.62 | 9.24 | 9.36 | 474,260 | |
05/22/2025 | 9.43 | 9.74 | 9.24 | 9.50 | 434,451 | |
05/21/2025 | 9.84 | 10.06 | 9.39 | 9.48 | 513,054 | |
05/20/2025 | 10.10 | 10.38 | 9.60 | 10.05 | 983,062 | |
05/19/2025 | 9.57 | 10.19 | 9.57 | 9.83 | 875,593 | |
05/16/2025 | 9.72 | 10.06 | 9.56 | 9.76 | 719,602 | |
05/15/2025 | 9.04 | 9.66 | 8.97 | 9.63 | 604,429 | |
| 05/14/2025 | 8.71 | 9.10 | 8.70 | 8.99 | 845,239 | |
05/13/2025 | 10.44 | 10.44 | 8.89 | 8.93 | 881,904 | |
05/12/2025 | 9.78 | 10.13 | 9.52 | 9.66 | 626,504 | |
05/09/2025 | 9.07 | 9.60 | 9.05 | 9.36 | 1,197,293 | |
05/08/2025 | 8.61 | 9.24 | 8.51 | 9.05 | 721,085 |
About Stoke Therapeutics Stock history
Stoke Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Stoke is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Stoke Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Stoke Therapeutics stock prices may prove useful in developing a viable investing in Stoke Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 54 M | 37.4 M | |
| Net Loss | -91 M | -86.4 M |
Stoke Therapeutics Quarterly Net Working Capital |
|
Stoke Therapeutics Stock Technical Analysis
Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Stoke Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Stoke Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Stoke Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Stoke to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1254 | |||
| Jensen Alpha | 0.3689 | |||
| Total Risk Alpha | 0.0533 | |||
| Sortino Ratio | 0.1143 | |||
| Treynor Ratio | 0.3649 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.82 | Revenue Per Share | Quarterly Revenue Growth 36.611 | Return On Assets | Return On Equity |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.